Bioceres Crop Solutions (BIOX) Projected to Post Quarterly Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) is projected to post its Q2 2026 results before the market opens on Tuesday, February 10th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $104.55 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, February 11, 2026 at 8:30 AM ET.

Bioceres Crop Solutions Stock Up 3.2%

Shares of NASDAQ BIOX opened at $0.86 on Tuesday. The company has a quick ratio of 0.64, a current ratio of 0.94 and a debt-to-equity ratio of 0.19. The company has a market cap of $54.64 million, a P/E ratio of -1.03 and a beta of 0.50. Bioceres Crop Solutions has a 52 week low of $0.83 and a 52 week high of $6.86. The business has a 50-day simple moving average of $1.37 and a two-hundred day simple moving average of $1.97.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Oppenheimer cut shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, October 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Canaccord Genuity Group lowered their price objective on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd. Finally, Wall Street Zen upgraded Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Bioceres Crop Solutions has an average rating of “Hold” and an average target price of $4.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp lifted its stake in Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. PDT Partners LLC lifted its position in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after buying an additional 10,449 shares during the last quarter. Virtu Financial LLC bought a new stake in Bioceres Crop Solutions in the 3rd quarter worth approximately $40,000. Finally, Jane Street Group LLC purchased a new stake in Bioceres Crop Solutions in the second quarter worth approximately $202,000. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.